Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.

Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, Serra C, Brandi G, Pinna AD.

Ann Surg. 2010 Jul;252(1):107-14. doi: 10.1097/SLA.0b013e3181e462e6.

PMID:
20531002
2.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
3.

Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.

PMID:
11995440
4.

Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Saxena A, Chua TC, Sarkar A, Chu F, Morris DL.

J Gastrointest Surg. 2010 Jul;14(7):1128-38. doi: 10.1007/s11605-010-1203-1. Epub 2010 May 14.

PMID:
20467830
5.

Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.

Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.

Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.

PMID:
18650638
6.

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y.

Cancer. 2003 Oct 15;98(8):1689-700.

7.

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR.

Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.

PMID:
18580211
8.

Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.

Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F.

Ann Surg Oncol. 2009 Feb;16(2):404-12. doi: 10.1245/s10434-008-0227-1. Epub 2008 Nov 27.

PMID:
19037702
9.

Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.

Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, Que FG, Crownhart B, Larson D, Nagorney DM.

Arch Surg. 2004 May;139(5):514-23; discussion 523-5.

PMID:
15136352
10.

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.

World J Surg. 2008 Dec;32(12):2675-80. doi: 10.1007/s00268-008-9778-3.

PMID:
18843437
11.

Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.

Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T.

Ann Surg Oncol. 2008 Oct;15(10):2787-94. doi: 10.1245/s10434-008-0081-1. Epub 2008 Aug 7.

PMID:
18685896
12.

Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.

Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S.

J Gastroenterol. 2006 Sep;41(9):893-900.

PMID:
17048054
13.

R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis.

Sotiropoulos GC, Bockhorn M, Sgourakis G, Brokalaki EI, Molmenti EP, Neuhäuser M, Radtke A, Wohlschlaeger J, Baba HA, Broelsch CE, Lang H.

Dig Dis Sci. 2009 Apr;54(4):887-94. doi: 10.1007/s10620-008-0408-6. Epub 2008 Aug 19.

PMID:
18712480
14.

Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.

PMID:
19130133
15.

Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.

Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okaya T, Shinmura K, Nakajima N.

J Am Coll Surg. 1999 Dec;189(6):575-83.

PMID:
10589594
16.

Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.

Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.

Hepatogastroenterology. 2007 Mar;54(74):346-9.

PMID:
17523271
17.
18.

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.

Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.

PMID:
19626372
19.

Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival.

Saxena A, Chua TC, Chu FC, Morris DL.

Am J Surg. 2011 Sep;202(3):310-20. doi: 10.1016/j.amjsurg.2010.08.041.

PMID:
21871986
20.

Survival analysis of intrahepatic cholangiocarcinoma after resection.

Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM.

Ann Surg Oncol. 2010 Jul;17(7):1823-30. doi: 10.1245/s10434-010-0938-y. Epub 2010 Feb 18.

PMID:
20165987
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk